Research Article

Prediction of Human Dihydroorotate Dehydrogenase Inhibitor Activity by a Weighted Average Ensemble-Based Prediction

Volume: 14 Number: 4 December 30, 2025
EN TR

Prediction of Human Dihydroorotate Dehydrogenase Inhibitor Activity by a Weighted Average Ensemble-Based Prediction

Abstract

This study concentrates on the weighted average ensemble-based prediction of pIC50 value for Human Dihydroorotate Dehydrogenase (hDHODH) using hybrid molecular fingerprints. By querying the ChEMBL database for IC50 data, a diverse collection of 1585 molecules was obtained, and these values were converted to pIC50 values to develop ensemble-based prediction models. We used the weighted average (W.Avg) of Light Gradient Boosting Machine (LGBM), Bootstrap Aggregating (Bagging), and Random Forest (RF) algorithms to estimate pIC50 values. Model performance was evaluated using 5x3 repeated K-fold cross-validation (CV). Root mean square error (RMSE) and mean squared error (MSE) were used as the performance metrics. The W.Avg combination demonstrated overall success beyond individual models. The results showed that our ensemble model outperformed all other baseline models with R²=0.8266, RMSE=0.6568, and MSE=0.4337. Paired t-test results indicate that the W.Avg model is statistically significantly superior to the other models in terms of R², RMSE, and MSE (p < 0.05). This ensemble-based method accelerated hDHODH inhibitor discovery by reducing screening time and increasing predictive accuracy.

Keywords

References

  1. Ganga, G.K.: Accelerating drug discovery targeting dihydroorotate dehydrogenase using machine learning and generative AI approaches. Comput Biol Chem, 118, 2025, p. 108443.
  2. Kawatani, M. et al.: Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling. Oncol Res, 31 (6), 2023, p. 833.
  3. Leban, J. et al.: Discovery of a novel series of DHODH inhibitors by a docking procedure and QSAR refinement. Bioorg Med Chem Lett, 14 (1), 2004, p. 55–58.
  4. Aqeel, I. et al.: Hybrid Approach to Identifying Druglikeness Leading Compounds against COVID-19 3CL Protease. Pharmaceuticals, 15 (11), 2022, p. 1333.
  5. Mendez, D. et al.: ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res, 47 (D1), 2019, p. D930–D940.
  6. Atasever, S.: Enhancing HCV NS3 Inhibitor Classification with Optimized Molecular Fingerprints Using Random Forest. Int J Mol Sci, 26 (6), 2025, p. 2680.
  7. Yang, J. et al.: Concepts and applications of chemical fingerprint for hit and lead screening. Drug Discov Today, 27 (11), 2022, p. 103356.
  8. Xie, L. et al.: Improvement of prediction performance with conjoint molecular fingerprint in deep learning. Front Pharmacol, 11, 2020, p. 606668.

Details

Primary Language

English

Subjects

Information Systems (Other), Biomedical Engineering (Other)

Journal Section

Research Article

Publication Date

December 30, 2025

Submission Date

October 10, 2025

Acceptance Date

December 8, 2025

Published in Issue

Year 2025 Volume: 14 Number: 4

APA
Sıramkaya, E., & Atasever, S. (2025). Prediction of Human Dihydroorotate Dehydrogenase Inhibitor Activity by a Weighted Average Ensemble-Based Prediction. Türk Doğa Ve Fen Dergisi, 14(4), 245-253. https://doi.org/10.46810/tdfd.1800883
AMA
1.Sıramkaya E, Atasever S. Prediction of Human Dihydroorotate Dehydrogenase Inhibitor Activity by a Weighted Average Ensemble-Based Prediction. TJNS. 2025;14(4):245-253. doi:10.46810/tdfd.1800883
Chicago
Sıramkaya, Eyüp, and Sema Atasever. 2025. “Prediction of Human Dihydroorotate Dehydrogenase Inhibitor Activity by a Weighted Average Ensemble-Based Prediction”. Türk Doğa Ve Fen Dergisi 14 (4): 245-53. https://doi.org/10.46810/tdfd.1800883.
EndNote
Sıramkaya E, Atasever S (December 1, 2025) Prediction of Human Dihydroorotate Dehydrogenase Inhibitor Activity by a Weighted Average Ensemble-Based Prediction. Türk Doğa ve Fen Dergisi 14 4 245–253.
IEEE
[1]E. Sıramkaya and S. Atasever, “Prediction of Human Dihydroorotate Dehydrogenase Inhibitor Activity by a Weighted Average Ensemble-Based Prediction”, TJNS, vol. 14, no. 4, pp. 245–253, Dec. 2025, doi: 10.46810/tdfd.1800883.
ISNAD
Sıramkaya, Eyüp - Atasever, Sema. “Prediction of Human Dihydroorotate Dehydrogenase Inhibitor Activity by a Weighted Average Ensemble-Based Prediction”. Türk Doğa ve Fen Dergisi 14/4 (December 1, 2025): 245-253. https://doi.org/10.46810/tdfd.1800883.
JAMA
1.Sıramkaya E, Atasever S. Prediction of Human Dihydroorotate Dehydrogenase Inhibitor Activity by a Weighted Average Ensemble-Based Prediction. TJNS. 2025;14:245–253.
MLA
Sıramkaya, Eyüp, and Sema Atasever. “Prediction of Human Dihydroorotate Dehydrogenase Inhibitor Activity by a Weighted Average Ensemble-Based Prediction”. Türk Doğa Ve Fen Dergisi, vol. 14, no. 4, Dec. 2025, pp. 245-53, doi:10.46810/tdfd.1800883.
Vancouver
1.Eyüp Sıramkaya, Sema Atasever. Prediction of Human Dihydroorotate Dehydrogenase Inhibitor Activity by a Weighted Average Ensemble-Based Prediction. TJNS. 2025 Dec. 1;14(4):245-53. doi:10.46810/tdfd.1800883

This work is licensed under the Creative Commons Attribution-Non-Commercial-Non-Derivable 4.0 International License.